NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00410813 2017-07-02S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneSWOG Cancer Research NetworkPhase 2 Completed85 enrolled 18 charts
NCT00371345 2011-04-26Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast CancerBristol-Myers SquibbPhase 2 Completed92 enrolled 27 charts